BDBM489627 (3R)-1-(5-(4-amino- 8-fluoro-6,7- dimethoxyquinazolin- 2-yl)-2,5-diazabicyclo- [2.2.2]octan-2-yl)-3- (ethylamino)-3-(4- fluorophenyl)propan- 1-one::US10961252, Cmp No. 15::US11248000, Cmp No. 15

SMILES CCN[C@H](CC(=O)N1CC2CCC1CN2c1nc(N)c2cc(OC)c(OC)c(F)c2n1)c1ccc(F)cc1

InChI Key InChIKey=QVVTXTALULUGCO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 489627   

TargetComplement factor B(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489627(US10961252, Cmp No. 15 | (3R)-1-(5-(4-amino- 8-flu...)
Affinity DataIC50: 1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2021
Entry Details
Go to US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489627(US10961252, Cmp No. 15 | (3R)-1-(5-(4-amino- 8-flu...)
Affinity DataIC50: 1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
Go to US Patent